The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Clinical COPD phenotypes: a novel approach using principal component and cluster analyses
Open accessAbstract
Classification of chronic obstructive pulmonary disease (COPD) is usually based on the severity of airflow limitation, which may not reflect phenotypic heterogeneity. Here, we sought to identify COPD phenotypes using multiple clinical variables. COPD subjects recruited in a French multicentre cohort were characterised using a standardised process. Principal component analysis (PCA) was performed using eight variables selected for their relevance to COPD: age, cumulative smoking, forced expiratory volume in 1 s (FEV 1) (% predicted), body mass index, exacerbations, dyspnoea (modified Medical Research Council scale), health status (St George’s Respiratory Questionnaire) and depressive symptoms (hospital anxiety and depression scale). Patient classification was performed using cluster analysis based on PCA-transformed data. 322 COPD subjects were analysed: 77% were male; median (interquartile range) age was 65.0 (58.0–73.0) yrs; FEV 1 was 48.9 (34.1–66.3)% pred; and 21, 135, 107 and 59 subjects were classified in Global Initiative for Chronic Obstructive Lung Disease (GOLD) stages 1, 2, 3 and 4, respectively. PCA showed that three independent components accounted for 61% of variance. PCA-based cluster analysis resulted in the classification of subjects into four clinical phenotypes that could not be identified using GOLD classification. Importantly, subjects with comparable airflow limitation (FEV 1) belonged to different phenotypes and had marked differences in age, symptoms, comorbidities and predicted mortality. These analyses underscore the need for novel multidimensional COPD classification for improving patient care and quality of clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
Lung volumes and forced ventilatory flows
Quanjer, P. H., Tammeling, G. J., Cotes, J. E., Pedersen, O. F., Peslin, R., & Yernault, J.-C. (1993) · European Respiratory Journal · doi:10.1183/09041950.005s1693 · Cited by 5,318
Rabe, K. F., Hurd, S., Anzueto, A., Barnes, P. J., Buist, S. A., Calverley, P., Fukuchi, Y., Jenkins, C., Rodriguez-Roisin, R., van Weel, C., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200703-456so · Cited by 4,925 · cited 7×
“Correlations between GOLD classes [1] and other variables were assessed using Kendall b rank correlation or logistic regression, as appropriate.”
BackgroundMethodInfluentialCelli, B. R., Cote, C. G., Marin, J. M., Casanova, C., Montes de Oca, M., Mendez, R. A., Pinto Plata, V., & Cabral, H. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa021322 · Cited by 4,015
(1993) · PubMed · Cited by 3,827
Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
Calverley, P. M. A., Anderson, J. A., Celli, B., Ferguson, G. T., Jenkins, C., Jones, P. W., Yates, J. C., & Vestbo, J. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063070 · Cited by 3,248
Jones, P. W., Quirk, F. H., Baveystock, C. M., & Littlejohns, P. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/145.6.1321 · Cited by 3,035
The St George's Respiratory Questionnaire
Jones, P. W., Quirk, F. H., & Baveystock, C. M. (1991) · Respiratory Medicine · doi:10.1016/s0954-6111(06)80166-6 · Cited by 2,683
Effect of Exacerbation on Quality of Life in Patients with Chronic Obstructive Pulmonary Disease
SEEMUNGAL, T. A. R., DONALDSON, G. C., PAUL, E. A., BESTALL, J. C., JEFFRIES, D. J., & WEDZICHA, J. A. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.5.9709032 · Cited by 2,312
Cluster analysis and clinical asthma phenotypes
Haldar, P., Pavord, I. D., Shaw, D. E., Berry, M. A., Thomas, M., Brightling, C. E., Wardlaw, A. J., & Green, R. H. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200711-1754oc · Cited by 1,987
A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease
Tashkin, D. P., Celli, B., Senn, S., Burkhart, D., Kesten, S., Menjoge, S., & Decramer, M. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805800 · Cited by 1,604
Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD
Mannino, D. M., Thorn, D., Swensen, A., & Holguin, F. (2008) · European Respiratory Journal · doi:10.1183/09031936.00012408 · Cited by 1,184
Ng, T.-P. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.1.60 · Cited by 624
Casanova, C., Cote, C., de Torres, J. P., Aguirre-Jaime, A., Marin, J. M., Pinto-Plata, V., & Celli, B. R. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200407-867oc · Cited by 597 · cited 1×
“8 independent variables (eigenvectors) called components [19].”
McGarvey, L. P., John, M., Anderson, J. A., Zvarich, M., & Wise, R. A. (2007) · Thorax · doi:10.1136/thx.2006.072348 · Cited by 561
Kent, D. M., & Hayward, R. A. (2007) · JAMA · doi:10.1001/jama.298.10.1209 · Cited by 505
Watz, H., Waschki, B., Boehme, C., Claussen, M., Meyer, T., & Magnussen, H. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200707-1011oc · Cited by 368
Burgel, P.-R., Nesme-Meyer, P., Chanez, P., Caillaud, D., Carré, P., Perez, T., & Roche, N. (2009) · Chest · doi:10.1378/chest.08-2062 · Cited by 346
Self-citationVestbo, J. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200505-969oc · Cited by 327
Detecting Stable Clusters Using Principal Component Analysis
Ben-Hur, A., & Guyon, I. (2003) · Functional Genomics · doi:10.1385/1-59259-364-x:159 · Cited by 252
Distinct clinical phenotypes of airways disease defined by cluster analysis
Weatherall, M., Travers, J., Shirtcliffe, P. M., Marsh, S. E., Williams, M. V., Nowitz, M. R., Aldington, S., & Beasley, R. (2009) · European Respiratory Journal · doi:10.1183/09031936.00174408 · Cited by 246
Curtis, J. R., Deyo, R. A., & Hudson, L. D. (1994) · Thorax · doi:10.1136/thx.49.2.162 · Cited by 230
Is nedocromil sodium effective treatment for asthma?
O'Byrne, P., & Cook, D. (1993) · European Respiratory Journal · doi:10.1183/09031936.93.06010005 · Cited by 223
Predictors of Survival in COPD: More than Just the FEV1
Celli, B. R., Côté, C., Lareau, S. C., & Meek, P. (2008) · Respiratory Medicine · doi:10.1016/s0954-6111(08)70005-2 · Cited by 172
Multi‐dimensional phenotyping: towards a new taxonomy for airway disease
Wardlaw, A. J., Silverman, M. A., Siva, R., Pavord, I. D., & Green, R. (2005) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2005.02344.x · Cited by 171
Physical Activity and Clinical and Functional Status in COPD
Garcia-Aymerich, J., Serra, I., Gómez, F. P., Farrero, E., Balcells, E., Rodríguez, D. A., de Batlle, J., Gimeno, E., Donaire-Gonzalez, D., Orozco-Levi, M., et al. (2009) · Chest · doi:10.1378/chest.08-2532 · Cited by 167
Vogt, W., & Nagel, D. (1992) · Clinical Chemistry · doi:10.1093/clinchem/38.2.182 · Cited by 101
Criner, G. J., & Sternberg, A. L. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200801-013et · Cited by 67
Celli, B. R. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200603-029ms · Cited by 61
Functional Genomics: Methods and Protocols
Brownstein, M., & Khodursky, A. B. (2007) · Cited by 49
Chest wall volume regulation during exercise in COPD patients with GOLD stages II to IV
Vogiatzis, I., Stratakos, G. K., Athanasopoulos, D., Georgiadou, O., Golemati, S., Koutsoukou, A., Weisman, I. M., Roussos, C., & Zakynthinos, S. G. (2008) · European Respiratory Journal · doi:10.1183/09031936.00155207 · Cited by 34
Chronic Obstructive Pulmonary Disease Phenotypes and Their Clinical Relevance
Mitchell, R. S. (2006) · Proceedings of the American Thoracic Society · Cited by 29
COPD and biomarkers: the search goes on
Turino, G. M. (2008) · Thorax · doi:10.1136/thx.2008.105957 · Cited by 14
Cited by
Inflammatory mechanisms in patients with chronic obstructive pulmonary disease
Barnes, P. J. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.05.011 · Cited by 1,683
Characterisation of COPD heterogeneity in the ECLIPSE cohort
the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators, Agusti, A., Calverley, P. M., Celli, B., Coxson, H. O., Edwards, L. D., Lomas, D. A., MacNee, W., Miller, B. E., Rennard, S., et al. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-122 · Cited by 1,157
“This observation is in keeping with recent observations by Burgel et al using principal component analysis and cluster analysis in a cohort of COPD subjects recruited in a French multicentre study [26].”
ResultBafadhel, M., McKenna, S., Terry, S., Mistry, V., Reid, C., Haldar, P., McCormick, M., Haldar, K., Kebadze, T., Duvoix, A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201104-0597oc · Cited by 1,094
Chronic Obstructive Pulmonary Disease Phenotypes: The Future of COPD
Han, M. K., Agusti, A., Calverley, P. M., Celli, B. R., Criner, G., Curtis, J. L., Fabbri, L. M., Goldin, J. G., Jones, P. W., MacNee, W., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200912-1843cc · Cited by 1,032
Chronic obstructive pulmonary disease
Decramer, M., Janssens, W., & Miravitlles, M. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60968-9 · Cited by 972
Metadata
- Authors
- Burgel, P.-R., Paillasseur, J.-L., Caillaud, D., Tillie-Leblond, I., Chanez, P., Escamilla, R., Court-Fortune, I., Perez, T., Carré, P., & Roche, N.
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2010-01-14
- Volume
- 36
- Issue
- 3
- Pages
- 531-539
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W2103647821
- Cited by
- 358
- References
- 33
- FWCI
- 23.86
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.